United States · FDA National Drug Code directory
Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43353-719_80c4cb36-638f-4d42-aa92-c5428ba5c547
- Product NDC
- 43353-719
- Form
- TABLET
- Composition / generic term
- Hydrochlorothiazide
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19730112
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET in 1 BOTTLE (43353-719-15) · 43353-719-15
- 30 TABLET in 1 BOTTLE (43353-719-30) · 43353-719-30
- 45 TABLET in 1 BOTTLE (43353-719-45) · 43353-719-45
- 60 TABLET in 1 BOTTLE (43353-719-53) · 43353-719-53
- 90 TABLET in 1 BOTTLE (43353-719-60) · 43353-719-60
- 100 TABLET in 1 BOTTLE (43353-719-65) · 43353-719-65
- 135 TABLET in 1 BOTTLE (43353-719-73) · 43353-719-73
- 180 TABLET in 1 BOTTLE (43353-719-80) · 43353-719-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →